Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Supernus Pharmaceuticals, Inc. SUPN

Set alert

Price alert · SUPN

All alert types
30.12 USD +1.97 +7.01%

As of Nov 3, 12:52 PM ET

Bid
30.08 × 7
Ask
30.14 × 1
28.35 Day range 31.62
28.35 52-week range 59.68
YTD
-39.39%
1 year
-45.92%
Open
28.35
Prev close
28.15
Mkt cap
1.75B
Vol
2.19M
Avg vol
850.44K
EPS
-0.76
P/E
0.00
Div yield
0.00%
More statistics
Low
28.35
High
31.62
Forward P/E
10.05
Beta
0.52
Short ratio
5.36
Inst. own
105.92%
Dividend
0.00
Ex-div date
Earnings
Feb 23, 2027
50-d avg
42.50
200-d avg
47.29
1y target
60.50

3M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Oct 29, 2026Earnings: 0.35; estimate 0.49; surprise -28.57%
Signals (21)
NameDateAgo
MACD: Sell SignalNov 3, 20263 hours ago
RSI: OversoldNov 3, 20263 hours ago
MACD: Buy SignalOct 22, 20261 week ago
RSI: OversoldOct 16, 20262 weeks ago
MACD: Sell SignalOct 14, 20262 weeks ago
SMA: BearishOct 8, 20263 weeks ago
SMA: BullishOct 7, 20263 weeks ago
SMA: BearishSep 30, 20261 month ago
SMA: BullishSep 28, 20261 month ago
MACD: Buy SignalSep 21, 20261 month ago
RSI: OversoldSep 15, 20261 month ago
MACD: Sell SignalAug 24, 20262 months ago
SMA: BearishAug 21, 20262 months ago
SMA: BearishAug 21, 20262 months ago
SMA: BullishAug 14, 20262 months ago
SMA: BearishAug 13, 20262 months ago
SMA: BullishAug 12, 20262 months ago
SMA: BearishAug 10, 20262 months ago
SMA: BullishAug 7, 20262 months ago
MACD: Buy SignalAug 7, 20262 months ago

Newest 20 of 21.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 60.50 +100.8% upside
Target (low)
55.00
Target (mean)
60.50
Target (high)
67.00
Ratings (0m) 4 3 buy · 1 hold · 0 sell
  • Strong buy0
  • Buy3
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 4
  • 1 month ago 4

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

SUPN analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter1.040.84 – 1.230.8821+17.3%230.85M+9.1%2
Next quarter0.380.38 – 0.38-0.04+1050.0%248.60M+19.7%1
Current year2.772.63 – 2.902.40+15.4%884.42M+23.0%2
Next year4.174.17 – 4.172.77+50.8%1.02B+15.3%1

Upgrades and downgrades

The latest rating changes

SUPN analyst upgrades and downgrades
DateFirmActionFromTo
Jul 9, 2026Cantor FitzgeraldMaintainedOverweightOverweight
Dec 19, 2025StifelMaintainedHoldHold
Oct 29, 2025B of A SecuritiesInitiated—Buy
Oct 23, 2025TD CowenMaintainedBuyBuy
Oct 9, 2025Piper SandlerUpgradeNeutralOverweight
Sep 30, 2025Cantor FitzgeraldMaintainedOverweightOverweight
Aug 29, 2025Piper SandlerMaintainedNeutralNeutral
Aug 6, 2025Cantor FitzgeraldMaintainedOverweightOverweight
Feb 26, 2025Cantor FitzgeraldReiteratedNeutralNeutral
Feb 19, 2025Cantor FitzgeraldDowngradeOverweightNeutral
Sep 11, 2024Piper SandlerDowngradeOverweightNeutral
Feb 28, 2024Piper SandlerMaintainedOverweightOverweight
Nov 9, 2023Piper SandlerMaintainedOverweightOverweight
Oct 25, 2023Piper SandlerMaintainedOverweightOverweight
May 10, 2023Piper SandlerMaintainedOverweightOverweight
Jan 23, 2023Piper SandlerMaintained—Overweight
Aug 31, 2022Piper SandlerMaintained—Overweight
Apr 13, 2021JefferiesUpgradeHoldBuy
Jun 16, 2020Piper SandlerUpgradeNeutralOverweight
Apr 16, 2020StifelMaintained—Hold
Nov 7, 2019StifelDowngradeBuyHold
Nov 6, 2019JefferiesDowngradeBuyHold
Dec 17, 2018MizuhoMaintainedBuyBuy
Nov 12, 2018B. Riley SecuritiesMaintainedBuyBuy
Sep 18, 2018MizuhoInitiated—Buy
Aug 9, 2018JefferiesMaintainedBuyBuy
May 25, 2018StifelMaintainedBuyBuy
Feb 1, 2018BerenbergInitiated—Buy
Dec 4, 2017Janney Montgomery ScottUpgradeNeutralBuy
Nov 8, 2017B. Riley SecuritiesMaintained—Buy